Franklin M. Berger, Director at Kezar Life Sciences, Inc. (KZR), bought 100,000 shares at $5.50 ($550K) on 2020-06-11, disclosed to the SEC on 2020-06-11.
Open-market purchase of $550k KZR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| EPIX | BUY | 2023-11-22 | $267K | — | Filing → |
| EPIX | BUY | 2023-11-16 | $518K | — | Filing → |
| EPIX | SELL | 2023-01-05 | $1.0M | — | Filing → |